Advertisement
U.S. markets open in 1 hour 49 minutes

RepliCel Life Sciences Inc. (REPCF)

OTC Markets EXMKT - OTC Markets EXMKT Delayed Price. Currency in USD
0.00020.0000 (0.00%)
At close: 03:00PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 464.93k
Enterprise Value 470.99k
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.04
Price/Book (mrq)N/A
Enterprise Value/Revenue 1.86
Enterprise Value/EBITDA -40.10

Trading Information

Stock Price History

Beta (5Y Monthly) 0.95
52-Week Change 3-99.70%
S&P500 52-Week Change 331.18%
52 Week High 30.0778
52 Week Low 30.0002
50-Day Moving Average 30.0240
200-Day Moving Average 30.0382

Share Statistics

Avg Vol (3 month) 31.57k
Avg Vol (10 day) 38.02k
Shares Outstanding 565M
Implied Shares Outstanding 62.32B
Float 823.06M
% Held by Insiders 159.39%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 3�
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Aug 10, 2016
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Aug 10, 2016

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 215.72%
Operating Margin (ttm)-74.14%

Management Effectiveness

Return on Assets (ttm)-153.34%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)353.74k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)0.00%
Gross Profit (ttm)N/A
EBITDA -819.31k
Net Income Avi to Common (ttm)763.08k
Diluted EPS (ttm)-0.0100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)148.95k
Total Cash Per Share (mrq)0
Total Debt (mrq)1.24M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.03
Book Value Per Share (mrq)-0.08

Cash Flow Statement

Operating Cash Flow (ttm)-235.39k
Levered Free Cash Flow (ttm)75.87k